Prosecution Insights
Last updated: April 19, 2026
Application No. 18/262,521

CURABLE RESIN COMPOSITION

Non-Final OA §102§103
Filed
Jul 21, 2023
Examiner
USELDING, JOHN E
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Adeka Corporation
OA Round
1 (Non-Final)
53%
Grant Probability
Moderate
1-2
OA Rounds
2y 9m
To Grant
71%
With Interview

Examiner Intelligence

Grants 53% of resolved cases
53%
Career Allow Rate
671 granted / 1262 resolved
-11.8% vs TC avg
Strong +18% interview lift
Without
With
+17.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
69 currently pending
Career history
1331
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
44.5%
+4.5% vs TC avg
§102
16.6%
-23.4% vs TC avg
§112
24.4%
-15.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1262 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 3-6, 9, 12, 13, 16, 19 and 20 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Arai et al. (JP 2011-219740A). Regarding claims 1, 3-6, 9, 12, 13, 16, 19 and 20: Arai et al. teach a one-component curing resin composition comprising 65 parts by mass epoxy resin (ELM434), 35 parts by mass curing agent (SEIKACURE-S), and 35 parts by mass of 3GPPI (N-(3-glycidyloxyphenyl)phthalimide) which meets claimed formula (1-3) of claim 1 [0140; Example 1]. Arai et al. teach a cured product of the composition [Example 1]. The molar proportion of the epoxy resin: curing agent: imide is 1.54:1.41:1.19 [Example 1]. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 2, 7, 8, 10, 11, 14, 15, 17 and 18 is/are rejected under 35 U.S.C. 103 as being unpatentable over Arai et al. (JP 2011-219740A) as applied to claim 1 above. Arai et al. teach using an imidazole as the curing agent [0097]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use an imidazole curing agent as the curing agent of Example 1. It is a simple substitution of one known element for another to obtain predictable results. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN USELDING whose telephone number is (571)270-5463. The examiner can normally be reached on M-F 8am to 6:30pm. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached on 571-272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOHN E USELDING/ Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Jul 21, 2023
Application Filed
Jan 29, 2026
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600669
SELF-HEALING POLYMER-MODIFIED CEMENTS FOR AMBIENT TEMPERATURE APPLICATIONS
2y 5m to grant Granted Apr 14, 2026
Patent 12600856
RESIN COMPOSITION, FORMED ARTICLE, AND, FORMED ARTICLE WITH HARD COAT LAYER
2y 5m to grant Granted Apr 14, 2026
Patent 12600809
ETHYLENE-VINYL ALCOHOL COPOLYMER COMPOSITION, AND PREPARATION METHOD THEREFOR
2y 5m to grant Granted Apr 14, 2026
Patent 12590214
INK-JET INK
2y 5m to grant Granted Mar 31, 2026
Patent 12583997
RESIN MOLDED BODY AND RESIN MOLDED BODY PRODUCTION METHOD
2y 5m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
53%
Grant Probability
71%
With Interview (+17.8%)
2y 9m
Median Time to Grant
Low
PTA Risk
Based on 1262 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month